Literature DB >> 17436102

CRP correlates with clinical score in ulcerative colitis but not in Crohn's disease.

Alexander D Rodgers1, Adrian G Cummins.   

Abstract

The aim of this study was to prospectively evaluate the correlation between clinical scoring systems and C-reactive protein (CRP) in inflammatory bowel disease. The modified Harvey-Bradshaw index was used in 40 patients (58 assessments) with Crohn's disease, and the Lichtiger score in 29 patients (36 assessments) with ulcerative colitis. In ulcerative colitis, CRP was elevated in 14%, 42%, 64%, and 83%, respectively, of subjects with quiescent, mild, moderate, and severe disease. There was a linear correlation of log(CRP) with clinical score except for proctitis. In Crohn's disease, CRP was elevated in 54%, 70%, 75%, and 100%, respectively, of subjects with quiescent, mild, moderate, and severe disease. We conclude that the clinical score has a good correlation with CRP in ulcerative colitis except for proctitis, whereas clinical score has a poor correlation with CRP in Crohn's disease, particularly in those with clinically quiescent, fibrostenotic, and ileal disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17436102     DOI: 10.1007/s10620-006-9691-2

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  Erythrocyte sedimentation as a measure of Crohn's disease activity: opposite trends in ileitis versus colitis.

Authors:  D B Sachar; N E Luppescu; C Bodian; R D Shlien; T L Fabry; V V Gumaste
Journal:  J Clin Gastroenterol       Date:  1990-12       Impact factor: 3.062

2.  Clinically active Crohn's disease in the presence of a low C-reactive protein.

Authors:  Timothy H J Florin; Ewan W J Paterson; Elizabeth V Fowler; Graham L Radford-Smith
Journal:  Scand J Gastroenterol       Date:  2006-03       Impact factor: 2.423

3.  Serum alpha 1-acid glycoprotein in chronic ulcerative colitis.

Authors:  W H Dearing; W F McGuckin; L R Elveback
Journal:  Gastroenterology       Date:  1969-02       Impact factor: 22.682

4.  Determining disease activity in inflammatory bowel disease.

Authors:  W T Cooke; P Prior
Journal:  J Clin Gastroenterol       Date:  1984-02       Impact factor: 3.062

5.  Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis.

Authors:  E A Fagan; R F Dyck; P N Maton; H J Hodgson; V S Chadwick; A Petrie; M B Pepys
Journal:  Eur J Clin Invest       Date:  1982-08       Impact factor: 4.686

Review 6.  Advances in the assessment of disease activity in inflammatory bowel disease.

Authors:  M Camilleri; M Proano
Journal:  Mayo Clin Proc       Date:  1989-07       Impact factor: 7.616

7.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

Authors:  W R Best; J M Becktel; J W Singleton; F Kern
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

8.  Cyclosporine in severe ulcerative colitis refractory to steroid therapy.

Authors:  S Lichtiger; D H Present; A Kornbluth; I Gelernt; J Bauer; G Galler; F Michelassi; S Hanauer
Journal:  N Engl J Med       Date:  1994-06-30       Impact factor: 91.245

9.  Correlation of various Crohn's disease activity indexes in subgroups of patients with primarily inflammatory or fibrostenosing clinical characteristics.

Authors:  C Papi; A Ciaco; M Bianchi; S Montanti; M Koch; L Capurso
Journal:  J Clin Gastroenterol       Date:  1996-07       Impact factor: 3.062

Review 10.  Laboratory markers in IBD: useful, magic, or unnecessary toys?

Authors:  S Vermeire; G Van Assche; P Rutgeerts
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

View more
  15 in total

1.  Activated inducible co-stimulator-positive programmed cell death 1-positive follicular helper T cells indicate disease activity and severity in ulcerative colitis patients.

Authors:  Y Long; X Zhao; Chang Liu; C Xia; Chen Liu
Journal:  Clin Exp Immunol       Date:  2020-07-28       Impact factor: 4.330

2.  Platelet Activation Markers Are Associated with Crohn's Disease Activity in Patients with Low C-Reactive Protein.

Authors:  Hiroshi Takeyama; Tsunekazu Mizushima; Hideki Iijima; Shinzaki Shinichiro; Mamoru Uemura; Junichi Nishimura; Taishi Hata; Ichiro Takemasa; Hirofumi Yamamoto; Yuichiro Doki; Masaki Mori
Journal:  Dig Dis Sci       Date:  2015-06-16       Impact factor: 3.199

Review 3.  The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease.

Authors:  James D Lewis
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

4.  A changing trend in the management of patients with newly diagnosed Crohn's disease.

Authors:  A Qasim; N Ullah; P Crotty; N Swan; N Breslin; B Ryan; W Torreggiani; E Eguare; P Neary; H O'Connor; C O'Morain
Journal:  Ir J Med Sci       Date:  2011-03-23       Impact factor: 1.568

Review 5.  Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives.

Authors:  Gian Eugenio Tontini; Maurizio Vecchi; Luca Pastorelli; Markus F Neurath; Helmut Neumann
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

6.  Assessing health status in inflammatory bowel disease using a novel single-item numeric rating scale.

Authors:  Bijal Surti; Brennan Spiegel; Andrew Ippoliti; Eric A Vasiliauskas; Peter Simpson; David Q Shih; Stephan R Targan; Dermot P B McGovern; Gil Y Melmed
Journal:  Dig Dis Sci       Date:  2012-12-19       Impact factor: 3.199

7.  Extensive Disease Subtypes in Adult Patients with Ulcerative Colitis: Non-pancolitis Versus Pancolitis.

Authors:  Dong Suk Shin; Jae Hee Cheon; Yong Eun Park; Yehyun Park; Soo Jung Park; Tae Il Kim; Won Ho Kim
Journal:  Dig Dis Sci       Date:  2018-08-25       Impact factor: 3.199

8.  Effects of an Oral Supplementation of Germinated Barley Foodstuff on Serum CRP Level and Clinical Signs in Patients with Ulcerative Colitis.

Authors:  Zeinab Faghfoori; Rahebeh Shakerhosseini; Lida Navai; Mohammad Hossein Somi; Zeinab Nikniaz; Alireza Abadi
Journal:  Health Promot Perspect       Date:  2014-07-12

9.  C-reactive protein and disease activity in children with Crohn's disease.

Authors:  Samantha Tilakaratne; Daniel A Lemberg; Steven T Leach; Andrew S Day
Journal:  Dig Dis Sci       Date:  2010-01       Impact factor: 3.199

10.  Increased folate intake with no changes in serum homocysteine and decreased levels of C-reactive protein in patients with inflammatory bowel diseases.

Authors:  P G Chiarello; F R O Penaforte; C C Japur; C D A S Souza; H Vannucchi; L E A Troncon
Journal:  Dig Dis Sci       Date:  2008-07-17       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.